Wealth Dimensions Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Wealth Dimensions Group's PFE Position: Q1 2026 in Review
Wealth Dimensions Group reduced its Pfizer (PFE) stake by 16% in Q1 2026, selling an estimated $129K and leaving 26,228 shares worth $736K. The position accounts for 0.14% of the portfolio, ranked #76.
Wealth Dimensions Group first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.04M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Wealth Dimensions Group held 26,228 shares of Pfizer worth $736K as of Q1 2026.
- Wealth Dimensions Group sold 4,837 Pfizer shares in Q1 2026, an estimated $129K.
- Pfizer made up 0.14% of Wealth Dimensions Group's portfolio in Q1 2026, its #76 holding.
- Wealth Dimensions Group first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- Wealth Dimensions Group's Pfizer position peaked at $1.04M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Wealth Dimensions Group's 13F filing for Q1 2026, filed 12 May 2026.